Radiological diagnostics of ovarian cancer;Radiologische Diagnostik des Ovarialkarzinoms

Radiologe

Volumn 51, Issue 7, 2011, Pages 581-588

  Meissnitzer, M ^a   Forstner, R ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

Computed tomography; Magnetic resonance imaging; Ovarian neoplasms; Staging; Ultrasonography

Indexed keywords

ARTICLE; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ENHANCEMENT; METHODOLOGY; OVARY TUMOR;

DIAGNOSTIC IMAGING; FEMALE; HUMANS; IMAGE ENHANCEMENT; OVARIAN NEOPLASMS;

EID: 79961209367     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-010-2120-8     Document Type: Article

References (25)

1. Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46(4):765-781
2. Forstner R (2007) CT and MRI in ovarian carcinoma. In: Hamm B, Forstner R (eds) MRI and CT of the female pelvis. Springer, Berlin Heidelberg New York, S 233-263
3. Hoskins P, Eisenhauer E, Vergote I et al (2000) Phase II feasibility study of sequential couplets of cisplatin/topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group Study. J Clin Oncol 18(24):4038-4044 (Pubitemid 32038395)
4. Boyd J (1998) Molecular genetics of hereditary ovarian cancer. Oncology 12(3):399-406 (Pubitemid 128617828)
5. Tavani A, Bosetti C, Dal Maso L et al (2004) Influence of selected hormonal and lifestyle factors on familial propensity to ovarian cancer. Gynecol Oncol 92(3):922-926 (Pubitemid 38251397)
6. Goff BA, Mandel LS, Drescher CW et al (2007) Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer 109(2):221-227 (Pubitemid 46106236)
7. Coakley FV (2002) Staging ovarian cancer: role of imaging. Radiol Clin North Am 40(3):609-636 (Pubitemid 34765043)
8. Forstner R, Sala E, Kinkel K, Spencer JA (2010) ESUR guidelines: ovarian cancer staging and follow-up. Eur Radiol 20(12):2773-2780
9. Spencer JA, Forstner R, Cunha TM, Kinkel K (2010) ESUR guidelines for MR imaging of the sonographically indeterminate adnexal mass: an algorithmic approach. Eur Radiol 20(1):25-35
10. Brown DL (2007) A practical approach to the ultrasound characterization of adnexal masses. Ultrasound Q 23(2):87-105 (Pubitemid 46849936)
11. Thomassin-Naggara I, Toussaint I, Perrot N et al (2011) Characterization of complex adnexal masses: Value of adding perfusionand diffusionweighted MR imaging to conventional mr imaging. Radiology 258:793-803
12. Adusumilli S, Hussain HK, Caoili EM et al (2006) MRI of sonographically indeterminate adnexal masses. AJR Am J Roentgenol 187(3):732-740 (Pubitemid 44651498)
13. Sohaib SA, Mills TD, Sahdev A et al (2005) The role of magnetic resonance imaging and ultrasound in patients with adnexal masses. Clin Radiol 60(3):340-348 (Pubitemid 40260268)
14. Tsili AC, Tsampoulas C, Charisiadi A et al (2008) Adnexal masses: accuracy of detection and differentiation with multidetector computed tomography. Gynecol Oncol 110(1):22-31
15. Chang W, Meux MD, Yeh BM et al (2006) CT and MRI of adnexal masses in patients with primary nonovarian malignancy. AJR Am J Roentgenol 186(4):1039-1045 (Pubitemid 46100205)
16. Spencer JA (2005) A multidisciplinary approach to ovarian cancer at diagnosis. Br J Radiol 78:94-102
17. Spencer JA, Swift SE, Wilkinson N et al (2001) Peritoneal carcinomatosis: image-guided peritoneal core biopsy for tumor type and patient care. Radiology 221(1):173-177 (Pubitemid 32880385)
18. Griffin N, Grant LA, Freeman SJ et al (2009) Imageguided biopsy in patients with suspected ovarian carcinoma: a safe and effective technique? Eur Radiol 19(1):230-235
19. Crijns AP, Duiker EW, Jong S de et al (2006) Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy. Int J Gynecol Cancer 16(suppl 1):152-165
20. Benedet JL, Bender H, Jones H 3rd et al (2000) FI- GO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70(2):209-262
21. Akin O, Sala E, Moskowitz CS et al (2008) Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion. Radiology 248(2):511-517
22. Tingulstad S, Skjeldestad FE, Halvorsen TB, Hagen B (2003) Survival and prognostic factors in patients with ovarian cancer. Obstet Gynecol 101:885-891 (Pubitemid 36561249)
23. Qayyum A, Coakley FV, Westphalen AC et al (2005) Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol 96(2):301-306 (Pubitemid 40127125)
24. Vergote I, Trope CG, Amant F et al (2010) Neoadjuvant chemotherapy or primary surgery in stage II- IC or IV ovarian cancer. N Engl J Med 363(10):943-953
25. Spencer JA, Forstner R, Hricak H (2008) Investigating women with suspected ovarian cancer. Gynecol Oncol 108(2):262-264 (Pubitemid 351174288)